Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Medical Research Methodology
Published in: BMC Medical Research Methodology 1/2019

Open Access 01-12-2019 | Opioids | Research article

Cross-cultural adaptation of the Pain Medication Questionnaire for use in Brazil

Authors: Sheila Raposo Galindo, Manoel Henrique da Nóbrega Marinho, Robert J. Gatchel, Tatiana de Paula Santana da Silva, Eduardo Henrique Soares Viana, Selene Cordeiro Vasconcelos, Murilo Duarte da Costa Lima

Published in: BMC Medical Research Methodology | Issue 1/2019

Login to get access

Abstract

Background

The Pain Medication Questionnaire (PMQ) assesses the risk of opioid abuse in people with non-oncological chronic pain.

Methods

This is a methodological study conducted at a hemotherapy centre in Recife, Pernambuco state, Brazil. A Cross-cultural adaptation was carried out by a committee of nine specialists, and we applied the PMQ to a pre-final sample of 40 individuals with sickle cell anemia, in addition to a sociodemographic and clinical questionnaire.

Results

The mean agreement indexes for PMQ equivalences were the following: semantic (0.996), idiomatic (0.970), experiential (0.991), conceptual (0.953), language clarity (0.991), practical relevance (0.906), and theoretical relevance (0.945). Assessment of the PMQ showed that 50% of participants obtained a score equivalent to medium risk of opioid abuse. Cronbach’s alpha coefficient for the adapted PMQ instrument was 0.705, ranging from 0.641 to 0.736 among its items.

Conclusion

The cross-cultural adaptation of the Pain Medication Questionnaire was satisfactory and easy to apply in the Brazilian population. It is clinically relevant, contributing professional practice and enlightening patients with sickle cell anemia on their behavioral dynamics with respect to opioid consumption. It will also contribute to teaching and research, because it is a useful tool for investigating the risk of abusive behavior in people with chronic pain.
Appendix
Available only for authorised users
Literature
1.
Embury S. Sickle cell disease: basic principles and clinical practice. New York: Raven Press; 1994. p. 599–621.
2.
Azevedo C. Anemia Falciforme. Brasília: Manual de Estudante de Hematologia Ministério da Saúde; 2005. p. 12–6.
3.
Felix A, Souza H, Ribeiro S. Aspectos epidemiológicos e sociais da doença falciforme. Rev Bras Hematol Hemoter. 2010;32(3):203–8.CrossRef
4.
Figueiredo JO. Morbidade e mortalidade por doença falciforme em Salvador, Bahia. [Dissertação]. Mestrado em Saúde Coletiva, Instituto de Saúde Coletiva da Universidade Federal da Bahia. 2017.
5.
Platt O, Thorington B, Brambilla D. Pain in sickle cell disease: rates and risk factors. N Engl J Med. 1991;325:11–6.CrossRef
6.
Platt O. Mortality in sickle cell disease. N Engl J Med. 1994;1994(331):1022–3.
7.
Campbell C. An evaluation of central sensitization in patients with sickle cell disease. J Pain. 2016;17(5):617–27.CrossRef
8.
Brandow A, Farley R, Panepinto J. Neuropathic pain in patients with sickle cell disease. Pediatr Blood Cancer. 2014;61(3):512–7.CrossRef
9.
Ezenwa M, Molokie R, Wang Z, Yao Y, Suarez M, Pullum C, et al. Safety and utility of quantitative sensory testing among adults with sickle cell disease: indicators of neuropathic pain? Pain Pract. 2016;16(3):282–3.CrossRef
10.
Smith W, Scherer M. Sickle-cell pain: advances in epidemiology and etiology. ASH Educ Program Book. 2018;1:409–15.
11.
Herdman M, Fox-Rushby J, Badia X. “Equivalence” and the translation and adaptation of health - related quality of life questionnaires. Qual Life Res. 1997;6(3):237–47.CrossRef
12.
Almeida L. Avaliação Psicológica –Exigências e desenvolvimento nos seus métodos. S M Wechsler,& R S Guzzo (Orgs),Avaliação psicológica –perspectiva internacional 2005;2:41–55.
13.
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417–32.CrossRef
14.
Adams L, Gatchel R, Robinson R, Polatin P, Gajraj N, Deschner M, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain pateints. J Pain Symptom Manag. 2004;27:440–59.CrossRef
15.
Holmes C, Gatchel R, Adams L, Stowell A, Hatten A, Noe C. An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire. Pain Pract. 2006;6(2):74–88.CrossRef
16.
Dowling L, Gatchel R, Adams L, Stowell A, Bernstein D. An evaluation of the predictive validity of the pain medication questionnaire with a heterogeneous group of patients with chronic pain. J Opioid Manag. 2007;3(5):257–66.CrossRef
17.
Buelow A, Haggard R, Gatchel R. Additional validation of the pain medication questionnaire in a heterogeneous sample of chronic pain patients. Pain Pract. 2009;9(6):428–34.CrossRef
18.
Ferrari R, Duse G, Capraro M, Visentin M. Risk assessment of opioid misuse in Italian patients with chronic noncancer pain. Pain Res Treat. 2014;2014:1–9.CrossRef
19.
Beaton D. Recommendations for the cross-cultural adaptation of DASH & QuickDASH outcome measures. [SI]: Institute for Work & Health; 2007.
20.
Fehring RJ. Methods to validate nursing diagnoses. Heart Lung. 1987;16(6):635–29.
21.
22.
Polit D, Beck C. Fundamentos de pesquisa em enfermagem: avaliação de evidências para a prática da enfermagem, vol. 7. Porto Alegre: Artmed; 2011.
23.
IBM-SPSS 23.0. Statistical Package for the Social Sciences (versão em Português). [Internet]. [cited 20 January 2017];Software. Available from: https://​www.​ibm.​com
24.
Cronbach J. Test “reliability”: its meaning and determination. Psychometrika. 1947;12(1):1–16.CrossRef
25.
Oliveira M. Cross-adaptation and validation of maternal postpartum quality of life questionnaire: applied in Brazilian mothers. Ana Karina Bezerra Pinheiro: Professor, vol. 177; 2014. p. 26.
26.
Gliem J, Gliem R. Calculating, interpreting, and reporting Cronbach’s alpha reliability coefficient for Likert-type scales. Presented at the Midwest Research-to-Practice Conference in Adult, Continuing, and Community Education, The Ohio State University, Columbus, OH; 2003. p. 82–8.
27.
Coluci MZO, Alexandre NMC, Milani D. Construção de instrumentos de medida na área da saúde. Ciência & Saúde Coletiva. 2015;20:925–36.
28.
Scatena L, Wysocki A, Beraldo A, Magnabosco G, Brunello M, Netto A. Validity and reliability of a health care service evaluation instrument for tuberculosis. Rev Saúde Pública. 2015;49:1–11.CrossRef
29.
Freitas S, Ivo M, Figueiredo M, Gerk M, Nunes C, Monteiro F. Quality of life in adults with sickle cell disease: an integrative review of the literature. Rev Bras Enferm. 2018;71(1):195–205.CrossRef
30.
Araujo D, Martins F, Santos T, Eleuterio R, Pedrosa A, Lemes R. Avaliação epidemiológica dos pacientes com anemia falciforme do estado do Ceará. Fortaleza: Encontros Universitários da UFC; 2016. p. 1.
31.
Breivik H, Collett B, Ventafridda V, Gallacher D, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287–333.CrossRef
32.
Benton T, Ifeagwu J, Smith-Witley K. Anxiety and depression in children and adolescents with sickle cell disease. Curr Psychiatry Rep. 2007;9(2):114–21.CrossRef
33.
Leverson J. Psychiatric issues in adults with sickle cell disease. Prim Psychiatry. 2008;15(5):45–9.
34.
Mateu G, Astals M, Torrens M. Comorbilidad psiquiátrica y trastorno por dependencia de opiáceos: del diagnóstico al tratamiento. Adicciones. 2005;17(2):111–21.
35.
Katon W. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216–26.CrossRef
36.
Eneh C. Nocturnal enuresis: prevalence and risk factors among school-aged children with sickle cell anemia in a South-east Nigerian city. Ital J Pediatr. 2015;41(66):1–6.
37.
Wolf R. Nocturnal enuresis in sickle cell disease. Expert Rev Hematol. 2014;7(2):245–54.CrossRef
38.
Saúde (BR) M. Protocolo Clínico e Diretrizes Terapêuticas Doença Falciforme. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. 2016.
39.
Chabal C, Erjavec M, Jacobson L. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain. 1997;13:150–5.CrossRef
40.
Compton P, Darakjian MA, Miotto K. Screening for addiction in patients with chronic pain and “problematic” substance use: evaluation of a pilot assessment tool. J Pain Symptom Manag. 1998;16:355–63.CrossRef
41.
Gupta M, Msambichaka L, Ballas S, Gupta K. Morphine forthe treatment of pain in sickle cell disease. Sci World J. 2015;2015:1–10.CrossRef
42.
Nascimento D, Sakata R. Dependência de opioide em pacientes com dor crônica. Rev Dor São Paulo. 2011;12(2):160–5.
43.
Coluzzi F, Taylor R, Pergolizzi J, Mattia C, Raffa R. Good clinical practice guide for opioids in pain management: the three Ts – titration (trial), tweaking (tailoring), transition (tapering). Bra J Anesthesiol. 2018;66(3):310–7.CrossRef
44.
Krause J, Clark J, Saunders J. Pain medication misuse among participants with spinal cord injury. Spinal Cord. 2015;53:630–5.CrossRef
45.
Gauntlett-Gilbert J, Gavriloff D, Brook P. Benzodiazepines may be worse than opioids: negative medication effects in severe chronic pain. Clin J Pain. 2016;32(4):285–91.CrossRef
46.
Bruera E, Paice J. Cancer pain management: safe and effective use of opioids. In: American Society of Clinical Oncology educational book American Society of Clinical Oncology; 2015. p. 593.
47.
Ferrari R, Zanolin M, Duse G, Visentin M. Effectiveness of opioid analgesics in chronic noncancer pain. Pain Pract. 2015;15(3):272–8.CrossRef
48.
Tran H, Gupta M, Gupta K. Targeting novel mechanisms of pain in sickle cell disease. Blood. 2017;133(22):2377–85.CrossRef
49.
Grattan A, Sullivan M, Saunders K, Campbell C, Von Korff M. Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med. 2012;10(4):304–11.CrossRef
50.
Hah J, Sturgeon J, Zocca J, Sharifzadeh Y, Mackey S. Factors associated with prescription opioid misuse in a cross-sectional cohort of patients with chronic non-cancer pain. J Pain Res. 2017;10:979–87.CrossRef
51.
Katz C, El-Gabalawy R, Keyes K, Martin S, Sareen J. Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample. Drug Alcohol Depend. 2013;132(1):107–13.CrossRef
52.
Dobscha S, Morasco B, Duckart J, Macey T, Deyo R. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. Clin J Pain. 2013;29(2):102.CrossRef
53.
Hojsted J, Ekholm O, Kurita G, Juel K, Sjogren P. Addictive behaviors related to opioid use for chronic pain: a population-based study. Pain. 2013;154(12):2677–83.CrossRef
54.
Ballas S. Sickle Cell Pain. Washington, DC: IASP Press; 2014.
55.
Clark J, Cao Y, Krause J. Risk of pain medication misuse after spinal cord injury: the role of substance use, personality, and depression. J Pain. 2017;18(2):166–77.CrossRef
56.
Hand B, Velozo C, Krause J. Rasch measurement properties of the Pain Medication Questionnaire in persons with spinal cord injury. Spinal Cord.2017; 55(12):1117–22.CrossRef
57.
Pasquali L. Instrumentação psicológica: Fundamentos e práticas. Porto Alegre: Artmed; 2010.
Metadata
Title
Cross-cultural adaptation of the Pain Medication Questionnaire for use in Brazil
Authors
Sheila Raposo Galindo
Manoel Henrique da Nóbrega Marinho
Robert J. Gatchel
Tatiana de Paula Santana da Silva
Eduardo Henrique Soares Viana
Selene Cordeiro Vasconcelos
Murilo Duarte da Costa Lima
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2019
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-019-0821-x

Other articles of this Issue 1/2019

BMC Medical Research Methodology 1/2019 Go to the issue

Research article

Sample size calculations for model validation in linear regression analysis

Research article

Modeling perinatal mortality in twins via generalized additive mixed models: a comparison of estimation approaches

Research article

Development of an algorithm for evaluating the impact of measurement variability on response categorization in oncology trials

Research article

The current use of feasibility studies in the assessment of feasibility for stepped-wedge cluster randomised trials: a systematic review

Research article

Estimating the loss of lifetime function using flexible parametric relative survival models

Research article

Preventing bias from selective non-response in population-based survey studies: findings from a Monte Carlo simulation study